AINewsnow

NeuroScale Raises $150M Series C to Boost AI Drug Discovery

This story is from 2026-09-18. It is preserved in the archive; the latest stories are on the live feed.

Lead NeuroScale, the AI‑powered biotech startup, announced a $150 million Series C financing round on September 12, 2026. Led by Andreessen Horowitz with participation from Sequoia Capital and existing backers, the capital will accelerate the company’s platform to shorten drug discovery timelines a…

Read the full story at DEV Community — AI ↗

Timeline · 1 report

  1. 2026-09-18 23:08 · DEV Community — AI
    NeuroScale Raises $150M Series C to Boost AI Drug Discovery

More stories

  1. Introducing Kimi K3 on Amazon Bedrock — AWS Machine Learning Blog
  2. Introducing Amazon SageMaker HyperPod Inference Gateway — AWS Machine Learning Blog
  3. Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology
  4. Gemini Hacked Three Companies in First Known Breakout by Google’s AI — Wall Street Journal Technology
  5. Alibaba ships Qwen3.8-Omni-Flash to watch, listen and call tools — r/LocalLLM
  6. NVIDIA CEO Jensen Huang rejects ‘AI will end the world’ claim, yet cautions ‘we should go as fast as we can but...’ — Mint AI
  7. Meet the Data Agent in ChatGPT Work — OpenAI YouTube
  8. AI hallucination of Chinese nuclear components almost led to US military attack — Ars Technica AI

Get the daily brief of stories like this at 6:30 every morning →